Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Non Operating Income (2022 - 2025)

Cannabis Bioscience International Holdings' Non Operating Income history spans 4 years, with the latest figure at -$21091.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 5.98% year-over-year to -$21091.0; the TTM value through Nov 2025 reached -$157805.0, down 2.39%, while the annual FY2025 figure was -$127455.0, 22.85% up from the prior year.
  • Non Operating Income for Q4 2025 was -$21091.0 at Cannabis Bioscience International Holdings, down from -$7861.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $21299.0 in Q3 2024 and bottomed at -$106302.0 in Q2 2024.
  • The 4-year median for Non Operating Income is -$25503.5 (2023), against an average of -$32019.7.
  • The largest YoY upside for Non Operating Income was 525.55% in 2024 against a maximum downside of 9502.71% in 2024.
  • A 4-year view of Non Operating Income shows it stood at -$36278.0 in 2022, then increased by 17.54% to -$29916.0 in 2023, then skyrocketed by 33.48% to -$19901.0 in 2024, then fell by 5.98% to -$21091.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Non Operating Income are -$21091.0 (Q4 2025), -$7861.0 (Q3 2025), and -$76844.0 (Q2 2025).